TABLE 6.
LOS | P6 | P2 | Total OM | |
---|---|---|---|---|
Alveolar macrophages | ||||
Group 1† | 2.1 (8.7)‡§ | 0.0 (0.0) | 0.0 (0.0) | 0.0 (34.3)‡§ |
Group 2 | 12.1 (51.4) | 0.2 (2.0) | 0.1 (2.6) | 26.4 (52.8) |
Group 3 | 32.2 (58.1) | 0.0 (0.2) | 0.0 (0.7) | 81.0 (138.3) |
Kruskal Wallis p value | 0.002 | —‖ | —‖ | 0.0009 |
Blood macrophages | ||||
Group 1 | 438.4 (887.7) | 5.0 (9.2) | 45.1 (65.6) | 859.0 (1,393.7) |
Group 2 | 400.2 (796) | 1.0 (4.5) | 45.5 (167.7) | 470.4 (1,513.5) |
Group 3 | 180.9 (257.9) | 1.7 (2.5) | 36.1 (79.6) | 453.4 (569.6) |
Kruskal Wallis p value | 0.45 | 0.06 | 0.62 | 0.56 |
Definition of abbreviations: LOS = lipooligosaccharide; OM = outer membrane.
Alveolar and blood macrophages of each donor were treated with 1 μg/ml of each nontypeable H. influenzae antigen. Values correspond with data in Figure 5. Each value is expressed as median pg/ml (interquartile range).
Group 1, chronic obstructive pulmonary disease; Group 2, exsmokers; Group 3, nonsmokers.
p < 0.05, Group 1 versus Group 2 by Mann Whitney U rank test.
p < 0.05, Group 1 versus Group 3 by Mann Whitney U rank test.
p < 0.05, but values were considered too low for biological significance.